The Zantac heartburn drug recall recently took place in April 2020 by the U.S. Food & Drug Administration (FDA) because of unacceptable levels of a probable carcinogen. Zantac, known generically as ranitidine, is a drug prescribed more than 15 million times a year to patients for heartburn worldwide since 1983. Multiple manufacturers had already issued […]
